The company acknowledges that "early research suggests that GLP-1 medications may play a role in supporting multiple aspects of health, such as cardiovascular and metabolic function" while noting that "compounded microdose formulations have not been specifically studied for these effects, and results may vary." That framing reflects the honest state of the science: clinical interest in the GLP-1 mechanism is well-founded
Furthermore, combination therapy with GLP-1 agonists and metformin has normalized menstrual cycles in 72.5% of patients, compared to just 42.3% with metformin alone
Most of the strongest evidence comes from systematic reviews and network meta-analyses, which pool data from multiple randomized controlled trials to detect patterns that individual studies cannot reliably show
Type 1 diabetics may donate blood if: Blood sugar levels are consistently controlled There are no recent severe hypoglycaemia episodes There are no serious complications affecting the heart, kidneys, or nerves Type 1 diabetics should avoid donating blood if: They experience frequent low blood sugar episodes Blood sugar is very high on the donation day They feel dizzy, weak, or unwell Eating a balanced meal before donation, staying hydrated, and monitoring blood sugar levels afterwards are essential for safety
However, medication isnt the only way to support GLP-1 activity
"EC 2.9.1"
